ProQR Therapeutics (PRQR) Prepaid Assets (2013 - 2026)
ProQR Therapeutics (PRQR) posted Prepaid Assets of $3.7 million for Q1 2026, up 21.67% sequentially from $3.1 million in Q4 2025, and up 21.55% YoY from $3.1 million in Q1 2025.
ProQR Therapeutics (PRQR) Prepaid Assets (2013 - 2026) Analysis & Trends
ProQR Therapeutics has reported Prepaid Assets for 14 years, with the latest figure at $3.7 million in Q1 2026.
- Quarterly Prepaid Assets rose 21.55% year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (up 21.55% YoY) and the FY2025 annual result came in at $3.1 million, up 18.74% from the prior year.
- Prepaid Assets rose to $3.7 million in Q1 2026 per PRQR's latest filing, from $3.1 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $4.5 million in Q1 2022 and troughed at $853220.3 in Q4 2023.
- A 5-year average of $2.7 million and a median of $2.5 million in 2022 frame the typical range for Prepaid Assets.
- The widest YoY moves for Prepaid Assets: up 82950.63% in 2022, down 87.0% in 2022.
- Over 5 years, Prepaid Assets stood at $2.5 million in 2022, then tumbled by 65.85% to $853220.3 in 2023, then jumped by 201.83% to $2.6 million in 2024, then gained by 18.74% to $3.1 million in 2025, then gained by 21.67% to $3.7 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $3.7 million, $3.1 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.72 Mn |
| Dec 31, 2025 | 3.06 Mn |
| Sep 30, 2025 | 2.22 Mn |
| Jun 30, 2025 | 2.36 Mn |
| Mar 31, 2025 | 3.06 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Sep 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | 1.15 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 853,220.35 |
| Sep 30, 2023 | 3.92 Mn |
| Jun 30, 2023 | 2.38 Mn |
| Mar 31, 2023 | 2.33 Mn |
| Dec 31, 2022 | 2.50 Mn |
| Sep 30, 2022 | 3.13 Mn |
| Jun 30, 2022 | 4.44 Mn |
| Mar 31, 2022 | 4.54 Mn |
| Dec 31, 2021 | 3.59 Mn |
| Sep 30, 2021 | 24.07 Mn |
| Jun 30, 2021 | 4.53 Mn |